A novel EGFR-TKI inhibitor (cAMP-H(3)BO(3)complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes

PURPOSE: Although EGFR-TKIs (epidermal growth factor receptor tyrosine kinase inhibitors) induce favorable responses as first-line non-small cell lung cancer treatments, drug resistance remains a serious problem. Meanwhile, thermal therapy also shows promise as a cancer therapy strategy. Here we com...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Yongpeng, Huang, Chunliu, Zhang, Junfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593564/
https://www.ncbi.nlm.nih.gov/pubmed/28915593
http://dx.doi.org/10.18632/oncotarget.17628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593564/
https://www.ncbi.nlm.nih.gov/pubmed/28915593
http://dx.doi.org/10.18632/oncotarget.17628

Ejemplares similares